• Explore /
  • Poster
  • / LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis.

LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early-stage breast cancer at very low risk of metastasis.

Abstract Poster

Authors

null

Elise Deluche

Centre Hospitalier Universitaire, Limoges, France

Elise Deluche , Stefan Michiels , Daniele Fric , Christophe Perrin , Caroline Bailleux , Thomas Bachelot , Pascal Ko Kivok Yun , Gaetan De Rauglaudre , Marie-Ange Mouret-Reynier , Romauld Le Scodan , Ines Vaz-Luis , Magali Lacroix-Triki , Clara Guyonneau , Fabrice Andre

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT05297617

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS615)

DOI

10.1200/JCO.2023.41.16_suppl.TPS615

Abstract #

TPS615

Poster Bd #

445a

Abstract Disclosures

Similar Posters

First Author: Julia Foldi

First Author: Charles Geyer

First Author: Julia R. White

First Author: Christopher David Walden